MayoComplete
Precision testing for individual insights
MayoComplete disease-specific, next-generation sequencing hematology panels provide focused insights on genetic variations found in hematological cancers to optimize treatment outcomes. MayoComplete hematology testing includes both comprehensive and targeted assays.
Testing advantages
- Developed, validated, analyzed, and reported by experts.
- Guides decisions on optimal treatment options, including targeted immunotherapies.
- High accuracy and sensitivity.
- A full menu of complementary microarray, FISH, and IHC testing available, providing full-spectrum testing in one laboratory.
Clear answers, definitive reports
Because testing is complex and selecting the right assay can be challenging, our team of board-certified geneticists and genetic counselors is available to assist with questions related to testing options and results interpretation.
MayoComplete next-generation sequencing includes detailed reports that highlight diagnostic findings, therapeutic associations, availability of on- and off-label therapies, prognostic markers, and existence of applicable clinical trials that enable deeper understanding of the best treatment choices.